Anna Alisi

14.5k total citations · 3 hit papers
225 papers, 9.8k citations indexed

About

Anna Alisi is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Anna Alisi has authored 225 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Epidemiology, 76 papers in Endocrinology, Diabetes and Metabolism and 54 papers in Molecular Biology. Recurrent topics in Anna Alisi's work include Liver Disease Diagnosis and Treatment (160 papers), Diet, Metabolism, and Disease (65 papers) and Pancreatitis Pathology and Treatment (27 papers). Anna Alisi is often cited by papers focused on Liver Disease Diagnosis and Treatment (160 papers), Diet, Metabolism, and Disease (65 papers) and Pancreatitis Pathology and Treatment (27 papers). Anna Alisi collaborates with scholars based in Italy, United States and United Kingdom. Anna Alisi's co-authors include Valério Nobili, Nadia Panera, Antonella Mosca, Rita De Vito, Giorgio Bedogni, Luca Valenti, Clara Balsano, Ariel E. Feldstein, Carlo Agostoni and Melania Manco and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Anna Alisi

220 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

2016 557 citations Valério Nobili, Cristiano De Stefanis et al. profile →
Complications, morbidity and mortality of nonalcoholic fatty liver disease

2020 405 citations Antonella Mosca, Anna Alisi et al. profile →
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

2021 163 citations Déirdre Kelly, Anna Alisi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Alisi Italy	56	6.6k	3.4k	2.7k	1.9k	1.7k	225	9.8k
Giovanni Musso Italy	44	6.9k 1.0×	4.3k 1.3×	2.6k 1.0×	1.8k 0.9×	2.2k 1.3×	87	10.2k
Jian‐Gao Fan China	48	7.5k 1.1×	2.8k 0.8×	3.0k 1.1×	3.0k 1.6×	1.4k 0.8×	200	10.6k
Roberto Gambino Italy	55	7.0k 1.1×	4.5k 1.3×	3.4k 1.2×	1.8k 1.0×	2.5k 1.4×	200	12.7k
Marco Arrese Chile	50	6.8k 1.0×	2.4k 0.7×	2.2k 0.8×	2.9k 1.5×	1.2k 0.7×	243	11.0k
Naim Alkhouri United States	59	8.7k 1.3×	3.9k 1.1×	1.7k 0.6×	3.8k 2.0×	1.4k 0.8×	325	11.2k
Silvia Sookoian Argentina	49	5.8k 0.9×	2.8k 0.8×	1.6k 0.6×	1.9k 1.0×	1.4k 0.8×	139	8.6k
Frank A. Anania United States	44	5.7k 0.9×	2.1k 0.6×	2.3k 0.8×	2.6k 1.4×	1.3k 0.8×	81	8.7k
Jeffrey D. Browning United States	30	8.8k 1.3×	4.8k 1.4×	2.8k 1.0×	2.3k 1.2×	2.8k 1.6×	49	11.9k
Maurizio Cassader Italy	56	7.4k 1.1×	5.0k 1.5×	3.1k 1.1×	1.9k 1.0×	2.8k 1.6×	183	13.0k
Jörn M. Schattenberg Germany	50	6.7k 1.0×	2.5k 0.7×	1.6k 0.6×	3.4k 1.8×	1.0k 0.6×	332	9.2k

Countries citing papers authored by Anna Alisi

Since Specialization

Citations

This map shows the geographic impact of Anna Alisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Alisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Alisi more than expected).

Fields of papers citing papers by Anna Alisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Alisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Alisi. The network helps show where Anna Alisi may publish in the future.

Co-authorship network of co-authors of Anna Alisi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Alisi. A scholar is included among the top collaborators of Anna Alisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Alisi. Anna Alisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanwal, Abhinav, et al.. (2025). Impact of diabetes on cellular connections: Pathological insights and emerging therapeutic targets. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 19(8). 103300–103300.

Piazzo, Lorenzo, Fabio Mangini, Cristiano De Stefanis, et al.. (2024). The Use of Artificial Intelligence in the Liver Histopathology Field: A Systematic Review. Diagnostics. 14(4). 388–388. 9 indexed citations

Petrilli, Lucia Lisa, Jan Fröhlich, Anna Alisi, et al.. (2024). Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma. Molecular Diagnosis & Therapy. 29(1). 129–141. 1 indexed citations

Stefanis, Cristiano De, Valentina Doria, Marzia Bianchi, et al.. (2024). Comparison between two artificial intelligence models to discriminate cancerous cell nuclei based on confocal fluorescence imaging in hepatocellular carcinoma. Digestive and Liver Disease. 57(5). 1015–1020. 1 indexed citations

Mosca, Antonella, Melania Manco, Stefano Cianfarani, et al.. (2024). Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD). Metabolites. 14(1). 71–71. 14 indexed citations

Stefanis, Cristiano De, Manuela Mandrone, Ilaria Chiocchio, et al.. (2024). Citrus Pomace as a Source of Plant Complexes to Be Used in the Nutraceutical Field of Intestinal Inflammation. Antioxidants. 13(7). 869–869. 3 indexed citations

Alisi, Anna, et al.. (2023). Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design. Health Science Reports. 6(2). e1101–e1101. 3 indexed citations

Mann, Jake P., Benjamin Jenkins, Samuel Furse, et al.. (2022). Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults. Journal of Pediatric Gastroenterology and Nutrition. 74(6). 734–741. 6 indexed citations

Panera, Nadia, Annalisa Crudele, Antonella Smeriglio, et al.. (2022). Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis. Nutrients. 14(18). 3791–3791. 24 indexed citations

10.

Pomella, Silvia, et al.. (2022). New Insights on the Nuclear Functions and Targeting of FAK in Cancer. International Journal of Molecular Sciences. 23(4). 1998–1998. 26 indexed citations

11.

Crudele, Annalisa, Antonella Smeriglio, Nadia Panera, et al.. (2022). Hydroxytyrosol Recovers SARS-CoV-2-PLpro-Dependent Impairment of Interferon Related Genes in Polarized Human Airway, Intestinal and Liver Epithelial Cells. Antioxidants. 11(8). 1466–1466. 6 indexed citations

12.

Rossi, Silvia, Silvano Junior Santini, Gianpaolo Maggi, et al.. (2021). Using the Social Robot NAO for Emotional Support to Children at a Pediatric Emergency Department: Randomized Clinical Trial. Journal of Medical Internet Research. 24(1). e29656–e29656. 21 indexed citations

13.

Panera, Nadia, Silvia Cardarelli, Marco Scarsella, et al.. (2021). Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma. Cancers. 13(9). 2182–2182. 9 indexed citations

14.

Mosca, Antonella, Annalisa Crudele, Antonella Smeriglio, et al.. (2020). Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. Digestive and Liver Disease. 53(9). 1154–1158. 67 indexed citations

15.

Bedogni, Giorgio, Giuseppe De Matteis, Marta Fabrizi, et al.. (2019). Association of Bright Liver with the PNPLA3 I148M Gene Variant in 1-year-old Toddlers. The Journal of Clinical Endocrinology & Metabolism. 104(6). 2163–2170. 7 indexed citations

16.

Deodati, Annalisa, Josepmaria Argemí, Daniela Germani, et al.. (2018). The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life. PLoS ONE. 13(6). e0198490–e0198490. 15 indexed citations

17.

Nobili, Valério, Anna Alisi, Antonella Mosca, et al.. (2018). The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?. Antioxidants and Redox Signaling. 31(2). 127–133. 32 indexed citations

18.

Pampanini, Valentina, et al.. (2016). Expression of Type 1 Insulin-like Growth Factor Receptor (IGF-1R) in Liver of Obese Children with Non-alcoholic Fatty Liver Disease (NAFLD). 86. 1 indexed citations

19.

Cianfarani, Stefano, Elena Inzaghi, Anna Alisi, et al.. (2014). Insulin-Like Growth Factor-I and -II Levels Are Associated with the Progression of Nonalcoholic Fatty Liver Disease in Obese Children. The Journal of Pediatrics. 165(1). 92–98. 36 indexed citations

20.

Alisi, Anna & Valério Nobili. (2014). Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children. 55–61. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact